S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY

類似資料

• Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
  著者:: Jack G. Fisher, 等
  出版事項: (2022-11-01)
• Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy
  著者:: Yan Li, 等
  出版事項: (2024-10-01)
• P1425: ACTIVATED AND EXPANDED NATURAL KILLER CELLS TRANSDUCED WITH AN NKG2D CHIMERIC ANTIGEN RECEPTOR AGAINST ACUTE MYELOID LEUKEMIA
  著者:: L. Córdoba, 等
  出版事項: (2022-06-01)
• Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance
  著者:: Xiaowei Liu, 等
  出版事項: (2024-02-01)
• Improvement of NK Cell Cytotoxicity in Reconstituting NK Cells after Allogeneic Stem Cell Transplantation by Blocking NKG2A Checkpoint
  著者:: Mohammed Taha, 等
  出版事項: (2023-10-01)